Acrivon Therapeutics, Inc.'s total assets for Q1 2025 were $176.35M, a decrease of -10.30% from the previous quarter. ACRV total liabilities were $15.96M for the fiscal quarter, a -19.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.